Familial mineralocorticoid induced hypertension in the sultanate of oman.

about

Familial mineralocorticoid induced hypertension in the sultanate of oman.

Item

http://www.wikidata.org/entity/Q41976354

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Familial mineralocorticoid induced hypertension in the sultanate of oman.

@en

type

Item

label

Familial mineralocorticoid induced hypertension in the sultanate of oman.

@en

prefLabel

Familial mineralocorticoid induced hypertension in the sultanate of oman.

@en

P1476

Familial mineralocorticoid induced hypertension in the sultanate of oman

@en

P2093

Fatma Ben Abid

http://www.w3.org/2001/XMLSchema#string

Nicholas Jy Woodhouse

http://www.w3.org/2001/XMLSchema#string

Omayma T Elshafie

http://www.w3.org/2001/XMLSchema#string

Suhail A Doi

http://www.w3.org/2001/XMLSchema#string

P2860

Familial varieties of primary aldosteronism

Dexamethasone-suppressible hypertension.

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

Evolution of diagnostic criteria for primary aldosteronism: why is it more common in "drug-resistant" hypertension today?

Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.

Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.

Spironolactone responsive familial hypertension. A potentially high prevalence of mineralocorticoid disease in Oman.

Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.

Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity.

Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers

P304

165-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21748054

http://www.w3.org/2001/XMLSchema#string

P921

Oman

P932

3074815

http://www.w3.org/2001/XMLSchema#string